<b>Gapping up <br/>In reaction to strong earnings/guidance/Same-store-sales:</b><br/>ESIO +21.5%, STMP +14.9%, CENT +14.5%, SEDG +14.4%, FMSA +12.4%, TTWO +11.8%, BVX +11.6%, HLTH +11.5%, AYX +10.2%, PACB +9.1%, (also announced that NVGN will purchase 10 Sequel Systems, filed mixed securities offering), FORM +9%, FCPT +9%, HCLP +8.9%, NSIT +8.7%, OCLR +8.4%, ECR +7.8%, OSUR +7.7%, AAC +7.3%, TSLA +6.6%, DATA +6.2%, SUPN +5.8%, TGB +5.8%, HIIQ +5.6%, QLYS +5.4%, HIMX +5.1%, FIT +4.9%, BLDP +4.9%, AET +4.7%, CSLT +4.6%, CDW +4.6%, CEVA +4.4%, AXGN +4.3%, HUBS +4.1%, CHK +3.5%, BIVV +3%, WMGI +2.8%, CAVM +2.8%, RP +2.7%, (to acquire substantially all of the assets of On-Site Manager for approximately $250 million in cash), CPE +2.7%, CTSH +2.6%, GOLD +2.6%, ZNGA +2.5%, GPL +2.3%, KGC +2.2%, OAS +2%, BREW +1.8%, AIG +1.7%, CATM +1.6%, CA +1.5%, SRI +1.5%, CINF +1.4%, AGO +1.4%, TDOC +1.3%, ITRI +1.3%, MRO +1.3%, BMRN +1%, (also will expand its development plan for BMN 270 to include an additional Phase 3 study of the 4e13 vg/kg dose based on updated data as of July 28, 2017 from its ongoing open-label Phase 1/2 study of BMN 270), IAC +1%, GDI +1%, MASI +1%<br/><b>M&A news:</b><br/>SCLN +5% (SciClone Pharma in proxy statement discloses non-binding competing bid for $12.00/share)<br/>KTWO +4.2% (acquires the license to a portfolio of 17 issued and pending patents for expandable interbody technology; terms not disclosed)<br/>WYN +2.9% (Wyndham Worldwide to spin off the company's hotel business resulting in two separate, publicly traded companies; to explore strategic alternative for the European rental brands)<br/>TROX +2.5% (divests Alkali Business for $1.325 bln; issues Q2 guidance)<br/>NMRX +1.6% (Numerex Corp. to merge with Sierra Wireless in a stock-for-stock merger transaction; the Transaction is valued at ~$107 million)<br/>Select OCLR peers trading higher:<br/>AAOI +3.3%, FN +2.2%, FNSR +2.1%, NPTN +1.8%, IPHI +1.8%, LITE +1.8%, ACIA +1.5%, COHR +1.4%, INFN +1.3%<br/><b>Other news:</b><br/>ATVI +3.2% (following TTWO/ZNGA earnings and ahead of its own release tomorrow Aug 3)<br/>NVTA +2.1% (Baker Bros/15.1% active stake discloses participation in NVTA's 7/31 private placement)<br/>AMC +1.6% (modestly rebounding from 27% decline following guidance; moves up Q2 earnings release and conference call to August 4 before the open)<br/>CCXI +1.4% (Chief Medical Officer Dr. Petrus Bekker retires for family medical reasons)<br/>HZO +1.3% (approves a new 2 mln stock repurchase plan )<br/>CHGG +1.1% (increases/prices follow-on offering of 10 mln shares at $13.50 per share)<br/><b>Analyst comments:</b><br/>LC +2.2% (upgraded to Outperform at Oppenheimer)<br/>CAT +0.5% (upgraded to Neutral from Underweight at Atlantic Equities)<br/><b>Gapping down<br/>In reaction to disappointing earnings/guidance/same-store-sales:</b><br/>IPAS -30.8%, PMTS -28.7%, COMM -15.2%, TTMI -12.8%, RGR -11.7%, TSE -11.1%, HABT -10.3%, HIVE -10.2%, DDD -9.8%, MOH -9.4%, (also announces restructuring, withdraws outlook), MCEP -7.8%, CENX -7.4%, GLOG -7.3%, CAKE -6%, PE -5.8%, AREX -5.8%, HOLX -5.7%, AVP -5.1%, CBPO -5%, CHD -5%, MTBC -4.7%, TS -4.6%, LB -4.5%, AWK -4.3%, HK -3.8%, KCAP -3.7%, DISH -3.7%, NUS -3.4%, BRSS -3.3%, DWSN -3.3%, BDX -3.2%, TCAP -3.1%, EXK -3.1%, ABC -3%, SYMC -2.9%, (Symantec sells its Website Security and related PKI solutions to DigiCert for approx. $950 mln in cash and approx. 30% stake in the common stock equity of the DigiCert business at the closing of the transaction), CRHM -2.9%, TCS -2.9%, TTEK -2.8%, INN -2.8%, MTDR -2.7%, COT -2.7%, CF -2.5%, PRU -2.3%, CAMT -2.3%, CRIS -2.3%, ICL -2.3%, SQ -2.2%, EEP -2.2%, AXTA -2.2%, CLVS -2%, PK -2%, NGL -2%, CRUS -1.8%, EXEL -1.8%, GKOS -1.8%, RICE -1.8%, NNBR -1.7%, TNH -1.7%, EVC -1.6%, CLLS -1.6%, MIC -1.5%, HL -1.5%, LQDT -1.5%, LSI -1.4%, USAK -1.4%, BID -1.4%, NEFF -1.2%, ATO -1.2%, CWST -1.1%, BLL -1.1%<br/><b>M&A news:</b><br/>SWIR -7.8% (Numerex Corp. to merge with Sierra Wireless in a stock-for-stock merger transaction; the Transaction is valued at ~$107 million)<br/><b>Other news:</b><br/>AGRX -19.3% (to offer shares of its common stock in underwritten offering )<br/>DRRX -4.3% (Durect and Zogenix (ZGNX) have terminated their Development and License Agreement whereby Zogenix had the worldwide development and commercialization rights to Relday)<br/>FBP -4.2% (commences 20 mln common stock offering by the co and/or Thomas H. Lee Partners)<br/>AOBC -4.2% (following RGR earnings)<br/>MNK -3.6% ( issues statement on DOJ subpoena related to opioid products)<br/>PBYI -1.4% (CHMP has issued its Day-180 List of Outstanding Issues in the process of their ongoing regulatory review of its MAA for neratinib for the extended adjuvant treatment of HER2-positive early stage breast cancer in patients who have previously been treated with trastuzumab-based adjuvant therapy)<br/>AGTC -1.1% (appoints William Sullivan as CFO; CFO Larry Bullock is retiring)<br/>ORC -1% ( files prospectus to sell up to $125 million of shares of its common stock through an at-the-market program)<br/><b>Analyst comments:</b><br/>MAT -1.3% (downgraded to Underperform at DA Davidson)<br/>ALL -0.7% (downgraded yesterday to Hold from Buy at Deutsche Bank)<br/><br/>Briefińg.com